Librea, Nimfa E.

HRN: 21-44-55  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/16/2023
06/22/2023
IV
4.5g
Q6H
Infected Breast Mass, Left
Waiting Final Action 
06/17/2023
AZITHROMYCIN 500MG TABLET (TAB)
06/17/2023
06/21/2023
PO
500mg
OD
CAP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: